What is ColoWrap?
ColoWrap, Inc. operates at the intersection of medical engineering and clinical efficiency, specializing in a unique colonoscopy compression device. The company's flagship product eliminates the historical reliance on manual abdominal pressure and frequent patient repositioning, which are common sources of physical strain for healthcare providers and discomfort for patients. By streamlining the cecal intubation process, ColoWrap not only enhances the quality of diagnostic procedures but also mitigates the risk of musculoskeletal injuries among GI professionals. The company's commitment to advancing endoscopic safety is further supported by comprehensive training programs, ensuring that its technological solutions are seamlessly integrated into existing hospital and clinic workflows to improve overall patient outcomes.
How much funding has ColoWrap raised?
ColoWrap has raised a total of $149K across 1 funding round:
Debt
$149K
Debt (2021): $149K with participation from PPP
Key Investors in ColoWrap
PPP
Public-Private Partnership
What's next for ColoWrap?
With this late-stage capital injection, ColoWrap is strategically positioned to scale its manufacturing capabilities and expand its market penetration across major healthcare systems. The company is expected to prioritize the deployment of its compression technology to address the growing demand for ergonomic and efficient GI solutions. Future growth initiatives will likely focus on deepening clinical evidence through expanded research partnerships and broadening its distribution network to ensure that its safety-centric devices become the standard of care in endoscopy suites globally. As the firm transitions into this next phase of maturity, the focus remains on operational excellence and the continued refinement of its clinical support infrastructure.
See full ColoWrap company page
